Sign In
Buy BLCO
$14.87
-0.110 (-0.734%)
At Close: Jun 03, 2026
Bausch + Lomb to Participate in Citi Global Healthcare Conference
04:30pm, Tuesday, 18'th Nov 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation - Analyst/Investor Day Transcript
07:57pm, Monday, 17'th Nov 2025
Bausch + Lomb Corporation ( BLCO ) Bausch + Lomb Corporation - Analyst/Investor Day November 13, 2025 8:30 AM EST Company Participants Brenton Saunders - CEO & Chairman of the Board Osama Eldessouky -
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-k
Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of “Hold” by Analysts
01:55am, Saturday, 01'st Nov 2025
Shares of Bausch + Lomb Corporation (NYSE: BLCO - Get Free Report) have been given an average rating of "Hold" by the fifteen research firms that are covering the firm, MarketBeat reports. Two researc
Bausch + Lomb Corporation (BLCO) Q3 2025 Earnings Call Transcript
02:26pm, Wednesday, 29'th Oct 2025
Bausch + Lomb Corporation ( BLCO ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants George Gadkowski Brenton L. Saunders - CEO & Chairman Osama Eldessouky - Executive VP & CFO Y
Bausch + Lomb (BLCO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
10:36am, Wednesday, 29'th Oct 2025
While the top- and bottom-line numbers for Bausch + Lomb (BLCO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics
Bausch + Lomb (BLCO) Q3 Earnings Beat Estimates
09:05am, Wednesday, 29'th Oct 2025
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.17 per share a year ago.
Bausch + Lomb Announces Third-Quarter 2025 Results
06:58am, Wednesday, 29'th Oct 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quar
Activist Jana Takes Stake in Cooper, a Maker of Medical Devices
08:00pm, Sunday, 19'th Oct 2025
Bausch + Lomb is seen as a potential buyer for the contact-lens unit and the CEO said he would be interested.
BLCO vs. DHR: Which Stock Should Value Investors Buy Now?
12:41pm, Thursday, 02'nd Oct 2025
Investors looking for stocks in the Medical Services sector might want to consider either Bausch + Lomb (BLCO) or Danaher (DHR). But which of these two stocks offers value investors a better bang for
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
07:15am, Monday, 29'th Sep 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter
Bausch + Lomb Corporation (NYSE:BLCO ) Bausch + Lomb Corporation Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 7:45 AM EDT Company Participants Brenton L. Saunders - CEO &
Bausch + Lomb Announces Board Changes
05:01pm, Monday, 18'th Aug 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the Amend
Bausch + Lomb to Participate in Upcoming Investor Conferences
07:15am, Thursday, 14'th Aug 2025
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that members o
Bausch Lomb (BLCO) Q2 Revenue Rises 5%
10:46pm, Wednesday, 30'th Jul 2025
Bausch Lomb (BLCO) Q2 Revenue Rises 5%
